CAS 1638338-43-8
:Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
Navicixizumab
CAS:Navicixizumab, a bispecific VEGF/DLL4 inhibitor, pairs with Paclitaxel in ovarian and other cancer research.Color and Shape:LiquidNavicixizumab
CAS:<p>Bispecific monoclonal antibody targeting the Notch ligand delta-like 4 (DLL4) and VEGF</p>
